To evaluate the relevance of our findings in breast cancer patient samples, we mined the expression of PLK1 from the METABRIC dataset [26, 27] and observed that PLK1 is mostly expressed in patients with ERα negative and basal/claudin-low tumours (Fig. 1I, J). Here, ESR1 is linked to neoplasm.